Ozempic: The truth about new 'weight-loss' drugs - UCHealth, accessed April 22, 2025,
Why its different Unlike semaglutide, which targets only GLP-1, tirzepatide works on both GLP-1 and GIP receptors
Renal function testing becomes especially important because both GLP-1 medications and anticoagulants depend partly on kidney clearance
GLP-1 receptor agonists (GLP-1) are medications designed to help individuals lose weight
They are very effective for weight loss and metabolic health, but they can sometimes cause side effects like nausea, constipation, or reduced enjoyment of food
Patients should notice a decrease in appetite fairly swiftly, if not immediately, after the first dosage